Literature DB >> 1467439

MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group.

K Hartung1, R Coldewey, A Corvetta, H Deicher, J R Kalden, F Krapf, B Lang, H J Lakomek, B Liedvogel, H H Peter.   

Abstract

Anticardiolipin antibodies (aCL) and HLA-DR antigens were determined in 314 central European patients with systemic lupus erythematosus (SLE). Both HLA-DR4 and DR7 were increased in aCL-positive patients, and aCL were significantly associated with DRw53. The association between DRw53 and aCL was also apparent in those 17 patients with SLE and the anticardiolipin syndrome. There was no association between aCL and HLA-DQ or C4 alleles in SLE.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1467439     DOI： 10.3109/08916939209001909

Source DB:  PubMed          Journal:  Autoimmunity        ISSN： 0891-6934            Impact factor:   2.815


  9 in total

Review 1.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

2.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.

Authors:  Kenji Tanimura; Hui Jin; Tadahiro Suenaga; Satoko Morikami; Noriko Arase; Kazuki Kishida; Kouyuki Hirayasu; Masako Kohyama; Yasuhiko Ebina; Shinsuke Yasuda; Tetsuya Horita; Kiyoshi Takasugi; Koichiro Ohmura; Ken Yamamoto; Ichiro Katayama; Takehiko Sasazuki; Lewis L Lanier; Tatsuya Atsumi; Hideto Yamada; Hisashi Arase
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

Review 4.  Genetics of antiphospholipid syndrome.

Authors:  Tetsuya Horita; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

5.  No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; K Hartung; H Ehrfeld; H P Seelig; H G Deicher; G Brünnler; E Keller; E Albert
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus.

Authors:  Sharon A Chung; Chao Tian; Kimberly E Taylor; Annette T Lee; Ward A Ortmann; Geoffrey Hom; Robert R Graham; Joanne Nititham; Jennifer A Kelly; Jean Morrisey; Hui Wu; Hong Yin; Marta E Alarcón-Riquelme; Betty P Tsao; John B Harley; Patrick M Gaffney; Kathy L Moser; Susan Manzi; Michelle Petri; Peter K Gregersen; Carl D Langefeld; Timothy W Behrens; Michael F Seldin; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-08

7.  HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; H P Seelig; H Ehrfeld; M Renz; K Hartung; H Deicher; E Keller; C Nevinny-Stickel; E D Albert
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Results of a multicenter study. SLE Study Group.

Authors:  H Ehrfeld; K Hartung; M Renz; R Coldewey; H Deicher; M Fricke; J R Kalden; J Lakomek; H H Peter; D Schendel
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

9.  Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.

Authors:  M L Sanchez; K Katsumata; T Atsumi; F I Romero; M L Bertolaccini; A Funke; O Amengual; E Kondeatis; R W Vaughan; A Cox; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.